Molecular analysis of the genus Mitragyna existing in Thailand based on rDNA ITS sequences and its application to identify a narcotic species:: Mitragyna speciosa

被引:36
作者
Sukrong, Suchada
Zhu, Shu
Ruangrungsi, Nijsiri
Phadungcharoen, Thatree
Palanuvej, Chanida
Komatsu, Katsuko
机构
[1] Toyama Univ, Inst Nat Med, Dept Med Resources, Dev Pharmacognosy, Toyama 9300194, Japan
[2] Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Pharmacognosy, Bangkok 10330, Thailand
[3] Chulalongkorn Univ, Inst Hlth Res, Bangkok 10330, Thailand
关键词
Mitragyna; kratom; rDNA internal transcribed spacer (ITS); PCR-restriction fragment-length polymorphism (RFLP); identification;
D O I
10.1248/bpb.30.1284
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In Thailand, there are four Mitragyna species; M. speciosa, M. hirsuta, M. diversifolia, and M. rotundifolia. One, M. speciosa, is a narcotic plant and has medicinal importance for its opium-like effect. Since the use of M. speciosa has been forbidden in Thailand, the leaves of M. diversifolia or others are frequently used as substitutes but are not considered as effective. Therefore, accurate authentication of M. speciosa is essential for both medicinal and forensic purposes. The nucleotide sequences of internal transcribed spacers (ITS) and the 5.8S coding region of nuclear ribosomal DNA (rDNA) of the Mitragyna species were analyzed. The whole length of ITS1-5.8S-ITS2 region was 608 bp in M. speciosa, 607 bp in the other species. Nineteen sites of nucleotide substitutions and 3 sites of I-bp indels were observed, and M. speciosa showed specific sequence differed from the others. Based on the ITS sequences, a distinctive site recognized by a restriction enzyme Xma I in M. speciosa was found and then PCR-restriction fragment length polymorphism (RFLP) analysis was established to differentiate M. speciosa from the others. By the method, a 409-bp PCR fragment of ITS1-5.8S (partial) rDNA region from M. speciosa was cleaved into two fragments of 119 bp and 290 bp while the other species remained undigested. This method provides an effective and accurate identification of H. speciosa.
引用
收藏
页码:1284 / 1288
页数:5
相关论文
共 25 条
[1]   THE ITS REGION OF NUCLEAR RIBOSOMAL DNA - A VALUABLE SOURCE OF EVIDENCE ON ANGIOSPERM PHYLOGENY [J].
BALDWIN, BG ;
SANDERSON, MJ ;
PORTER, JM ;
WOJCIECHOWSKI, MF ;
CAMPBELL, CS ;
DONOGHUE, MJ .
ANNALS OF THE MISSOURI BOTANICAL GARDEN, 1995, 82 (02) :247-277
[2]   Origin and relationships of the tarweed-silversword lineage (Compositae-Madiinae) [J].
Baldwin, BG ;
Wessa, BL .
AMERICAN JOURNAL OF BOTANY, 2000, 87 (12) :1890-1908
[3]   Indole alkaloids of a Thai medicinal herb, Mitragyna speciosa, that has opioid agonistic effect in guinea-pig ileum [J].
Horie, S ;
Koyama, F ;
Takayama, H ;
Ishikawa, H ;
Aimi, N ;
Ponglux, D ;
Matsumoto, K ;
Murayama, T .
PLANTA MEDICA, 2005, 71 (03) :231-236
[4]  
HUYSMANS S, 1994, BLUMEA, V39, P321
[5]   PSYCHOACTIVE PROPERTIES OF MITRAGYNINE (KRATOM) [J].
JANSEN, KLR ;
PRAST, CJ .
JOURNAL OF PSYCHOACTIVE DRUGS, 1988, 20 (04) :455-457
[6]   NUCLEOTIDE-SEQUENCE OF A 17S (18S) RIBOSOMAL-RNA GENE FROM TOMATO [J].
KISS, T ;
SZKUKALEK, A ;
SOLYMOSY, F .
NUCLEIC ACIDS RESEARCH, 1989, 17 (05) :2127-2127
[7]   Species identification of Radix Astragali (Huangqi) by DNA sequence of its 5S-rRNA spacer domain [J].
Ma, XQ ;
Duan, JA ;
Zhu, DY ;
Dong, TTX ;
Tsim, KWK .
PHYTOCHEMISTRY, 2000, 54 (04) :363-368
[8]   Antinociceptive effect of 7-hydroxymitragynine in mice:: Discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa [J].
Matsumoto, K ;
Horie, S ;
Ishikawa, H ;
Takayama, H ;
Aimi, N ;
Ponglux, D ;
Watanabe, K .
LIFE SCIENCES, 2004, 74 (17) :2143-2155
[9]   Involvement of μ-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa [J].
Matsumoto, Kenjiro ;
Hatori, Yoshio ;
Murayama, Toshihiko ;
Tashima, Kimihito ;
Wongseripipatana, Sumphan ;
Misawa, Kaori ;
Kitajima, Mariko ;
Takayama, Hiromitsu ;
Horie, Syunji .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 549 (1-3) :63-70
[10]  
Mizukami H, 2000, BIOL PHARM BULL, V23, P589, DOI 10.1248/bpb.23.589